199 related articles for article (PubMed ID: 33560194)
61. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy.
Koshelev MV; Garrison PA; Wright TS
Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007
[TBL] [Abstract][Full Text] [Related]
62. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome.
Lindor NM; Arsenault TM; Solomon H; Seidman CE; McEvoy MT
Mayo Clin Proc; 1997 Jul; 72(7):611-5. PubMed ID: 9212761
[TBL] [Abstract][Full Text] [Related]
63. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome in a Chinese family: A case report and review of literature.
Lu LY; Tang XY; Luo GJ; Tang MJ; Liu Y; Yu XJ
World J Clin Cases; 2021 Aug; 9(22):6393-6402. PubMed ID: 34435004
[TBL] [Abstract][Full Text] [Related]
64. Pyogenic arthritis pyoderma gangrenosum and acne syndrome: A rare but important diagnosis for antibiotic-resistant erysipelas-like erythema and osteonecrosis.
Martini G; Meneghel A; Gigante C; Beltrame V; Serena T; Di Palma A
J Paediatr Child Health; 2018 Dec; 54(12):1378-1381. PubMed ID: 29943877
[No Abstract] [Full Text] [Related]
65. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
[TBL] [Abstract][Full Text] [Related]
66. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis).
Marzano AV; Damiani G; Ceccherini I; Berti E; Gattorno M; Cugno M
Br J Dermatol; 2017 Jun; 176(6):1588-1598. PubMed ID: 27943240
[TBL] [Abstract][Full Text] [Related]
67. Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome.
Omenetti A; Carta S; Caorsi R; Finetti M; Marotto D; Lattanzi B; Jorini M; Delfino L; Penco F; Picco P; Buoncompagni A; Martini A; Rubartelli A; Gattorno M
Rheumatology (Oxford); 2016 Jul; 55(7):1325-35. PubMed ID: 26989109
[TBL] [Abstract][Full Text] [Related]
68. Clinical and genetic characteristics of PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome.
Zhang D; Su G; Liu Y; Lai J
Pediatr Rheumatol Online J; 2021 Oct; 19(1):151. PubMed ID: 34620178
[TBL] [Abstract][Full Text] [Related]
69. [Multilocular pyoderma gangrenosum : Association with primary manifestation of primary biliary cholangitis].
Kögel J; Berneburg M; Karrer S; Drexler K; Niebel D
Dermatologie (Heidelb); 2023 Jul; 74(7):538-542. PubMed ID: 37326669
[TBL] [Abstract][Full Text] [Related]
70. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
Murphy B; Morrison G; Podmore P
Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
[No Abstract] [Full Text] [Related]
71. [Severe acne in autoinflammatory diseases].
Faleri S; Feichtner K; Ruzicka T
Hautarzt; 2016 Nov; 67(11):897-901. PubMed ID: 27448064
[TBL] [Abstract][Full Text] [Related]
72. Long-term Remission of Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome.
Brokamp G; Bechtel M; Chung C
Cutis; 2023 Jun; 111(6):E2-E6. PubMed ID: 37487120
[TBL] [Abstract][Full Text] [Related]
73. Perinuclear antineutrophil cytoplasmic antibody myeloperoxidase-positive vasculitis in association with ulcerative colitis.
Panani AD; Grigoriadou M; Magira E; Roussos C; Raptis SA
Clin Rheumatol; 2006 Feb; 25(1):35-7. PubMed ID: 15902516
[TBL] [Abstract][Full Text] [Related]
74. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome.
Stichweh DS; Punaro M; Pascual V
Pediatr Dermatol; 2005; 22(3):262-5. PubMed ID: 15916580
[TBL] [Abstract][Full Text] [Related]
75. PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition.
Saraceno R; Babino G; Chiricozzi A; Zangrilli A; Chimenti S
J Am Acad Dermatol; 2015 Jan; 72(1):e42-4. PubMed ID: 25497954
[No Abstract] [Full Text] [Related]
76. A child with recurrent pyogenic arthritis with the PSTPIP1 mutation.
Guo YN
SAGE Open Med Case Rep; 2020; 8():2050313X20918988. PubMed ID: 32477554
[TBL] [Abstract][Full Text] [Related]
77. PAPA-like syndrome with heterozygous mutation in the MEFV gene.
O'Connor C; Kiely L; Heffron C; Ryan J; Bennett M
Clin Exp Dermatol; 2022 Mar; 47(3):642-645. PubMed ID: 34882829
[TBL] [Abstract][Full Text] [Related]
78. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
Fattore D; Pistone G; Bongiorno MR
G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
[No Abstract] [Full Text] [Related]
79. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
[TBL] [Abstract][Full Text] [Related]
80. [Uncommon acne-associated syndromes and their significance in understanding the pathogenesis of acne].
Hong JB; Prucha H; Melnik B; Ziai M; Ring J; Chen W
Hautarzt; 2013 Apr; 64(4):274-9. PubMed ID: 23525534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
